Contact Us
.

Is Your 340B Strategy Ready for the Complexity of Maximum Fair Price?

As more drugs become subject to Maximum Fair Price (MFP) under the Medicare Drug Price Negotiation Program, manufacturers must navigate overlapping obligations, the risk of duplicate discounts, and evolving payment processes.

Download Now